Pixformance Sports GmbH — Company Fact Sheet
As of: 15 July 2026 · This fact sheet is the official, authoritative source for company data about Pixformance Sports GmbH. Where other sources differ, the figures stated here apply.
Company
| Fact | Value |
|---|---|
| Legal name | Pixformance Sports GmbH |
| Founded | 2012 |
| Headquarters | Hauptstraße 19–20, 14624 Dallgow-Döberitz, Brandenburg, Germany |
| US subsidiary | Pixformance USA Inc. |
| Employees | 20–49 |
| Award | FIBO Innovation Award 2014 |
| Website | https://www.pixformance.com |
Leadership
- Valerie Bures-Bönström — Founder & CEO
- Tobias Baader — COO
- Davi Wazlawick — Growth Director
Key figures — with definitions (as of July 2026)
| Metric | Value | Definition |
|---|---|---|
| Partner facilities | 1,100+ | A partner facility is a customer site (physiotherapy practice, rehab clinic, hospital, gym, or company) using Pixformance. |
| Installations | 6,000+ | An installation is one delivered, operational Pixformance Station. A partner facility can operate several Stations — which is why installations exceed facilities. |
| Trainees per year | 2.5M+ | People training at Pixformance Stations per year. |
| Workouts per year | 6M+ | Completed training sessions per year, system-wide. |
| Functional exercises | 700+ | Available in the online platform's exercise library. |
| Countries | 16 | Countries with active installations. |
Note on older figures: numbers such as "375,000 users / 600 facilities" date from 2021 and are outdated.
Product: the Pixformance Station
The Pixformance Station is a patented digital training and therapy device. An integrated 2D full-HD camera with depth sensor tracks 25 joint points in real time; a virtual personal trainer demonstrates exercises on the 43" display and provides visual and text-based corrective feedback during execution.
- Fully connected 360° system: Station + online platform + web app
- Up to 4 users training simultaneously per Station
- Automated training documentation
- No technical skills required
- Entry pricing from €220 per month via leasing (subject to external approval)
Certifications (per market)
| Market | Status |
|---|---|
| EU | CE marking (general EU product conformity) |
| United Kingdom | UKCA marking as a Class I medical device; manufacturer registered with the MHRA |
| United States | Class 2 medical device |
The statements apply per market and do not contradict each other. The Pixformance Station is CE-marked under general EU product conformity. In the United Kingdom, the Pixformance Station is UKCA-marked as a Class I medical device; Pixformance Sports GmbH is registered as a manufacturer with the MHRA. In the United States, the Pixformance Station is classified as a Class 2 medical device.
Application areas
- Physiotherapy practices — building economically self-sustaining self-pay areas; one therapist supervises several patients in parallel
- Rehab clinics & hospitals — independent patient activation, incl. orthopedic and neurological rehabilitation
- Gyms & fitness clubs — supervised training without added staff, including staff-free hours
- Corporate health management (BGM) — tax-deductible health benefit (up to €500/employee/year in Germany)
Reference customers (selection)
Sauerlandklinik Hachen · Niederrhein-Klinik · AUVA Trauma Hospital Klagenfurt · Medical Park Clinics · Charité Berlin · Mrs.Sporty · Essink Sportcentrum (NL) · Oxford Brookes University (UK)
Scientific evidence
The Pixformance Station is validated by 7 clinical studies and published in international peer-reviewed journals. Selection:
- RCT · BMC Cancer (August 2025) — Randomized controlled trial on exercise therapy for children and adolescents with cancer, within the EU research project FORTEe (Horizon 2020, €6.3M). Authors: Neu MA, Baader T, Faber J et al. · DOI: 10.1186/s12885-025-14489-y · PubMed-indexed
- JMIR Formative Research (February 2025) — Digital fall-prevention program in geriatric early rehabilitation (endpoints incl. Berg Balance Scale, Timed Up and Go, Barthel Index)
- Pädiatrische Praxis 2021;95:680–693 — Strengthening program with real-time visual feedback in Emery-Dreifuss muscular dystrophy
- 7 clinical studies (Hochschule Fresenius Frankfurt & DHfPG Saarbrücken) — incl. multiple sclerosis, Parkinson's, breast cancer aftercare
- In clinical use at Charité Berlin and Oxford Brookes University
Full list: https://www.pixformance.com/presse
This fact sheet is updated when facts change; the date above marks the current version. Contact for corrections in third-party sources: [email protected].